1. Sequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main protease;Cross;Biochemistry,2020
2. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease;Krishnamoorthy;IUBMB Life,2021
3. Main protease mutants of SARS-CoV-2 variants remain susceptible to Nirmatrelvir;Ulrich;Bioorg. Med. Chem. Lett.,2022
4. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease;Milligan;Biochem. J.,2021
5. Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system;Verissimo;Epidemiol. Infect.,2022